Cargando…
Application of an evidence-based, out-patient treatment strategy for COVID-19: Multidisciplinary medical practice principles to prevent severe disease()
The COVID-19 pandemic has devastated individuals, families, and institutions throughout the world. Despite the breakneck speed of vaccine development, the human population remains at risk of further devastation. The decision to not become vaccinated, the protracted rollout of available vaccine, vacc...
Autores principales: | Frohman, Elliot M., Villemarette-Pittman, Nicole R., Rodriguez, Adriana, Glanzman, Robert, Rugheimer, Sarah, Komogortsev, Oleg, Zamvil, Scott S., Cruz, Roberto Alejandro, Varkey, Thomas C., Frohman, Ashley N., Frohman, Audrey R., Parsons, Matthew S., Konkle, Emily Heckmann, Frohman, Teresa C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055502/ https://www.ncbi.nlm.nih.gov/pubmed/33971376 http://dx.doi.org/10.1016/j.jns.2021.117463 |
Ejemplares similares
-
Part I. SARS-CoV-2 triggered ‘PANIC’ attack in severe COVID-19
por: Frohman, Elliot M., et al.
Publicado: (2020) -
Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’ attack
por: Frohman, Elliot M., et al.
Publicado: (2020) -
Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019?
por: Maguire, Cole, et al.
Publicado: (2020) -
Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes
por: Racke, Michael K., et al.
Publicado: (2022) -
Mitigating alemtuzumab-associated autoimmunity in MS: A “whack-a-mole” B-cell depletion strategy
por: Meltzer, Ethan, et al.
Publicado: (2020)